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Evaluation of serum lipid abnormalities in chronic nephritis. progression. Although many reports have described the
Background. In glomerular disease, disorders of lipid me- dyslipidemia of renal disease, including nephrotic syn-
tabolism are suspected as factors exacerbating glomerular dys- drome and chronic renal failure [1, 2], there have beenfunction. Although many reports have been published regard-
few published studies describing lipid abnormalities ining metabolic disorders of lipids in renal disease, including
chronic nephritis. In particular, there has been no reportnephrotic syndrome and chronic renal failure, there have been
few published reports describing metabolic disorders of lipids on the relationship between renal function and protein-
in chronic nephritis. Therefore, in patients with IgA nephritis, uria to serum lipid levels. Therefore, in patients with
we evaluated correlations between serum lipid levels and renal
IgA nephritis, we evaluated the correlations betweenfunction and proteinuria.
serum lipid levels in patients with chronic nephritis andMethods. In 191 patients with IgA nephritis, we evaluated
the correlations between serum lipid levels and renal function renal function and proteinuria.
[creatinine clearance (CCr)] and proteinuria (UP). Serum lipids
examined included total cholesterol (TC), triglycerides (TG),
high-density lipoprotein cholesterol (HDL-C), low-density li- METHODS
poprotein cholesterol (LDL-C), apolipoproteins, phospholip-
Our study involved 191 patients (95 male and 96 fe-ids (PL), lipoprotein(a) [Lp(a)], and malondialdehyde (MDA).
male; mean age, 35.0 6 14.0 years; age range, 13 6 67Results. Significant correlations were observed between se-
rum lipid levels and CCr, UP, and age. There were no abnormali- years) with IgA nephritis who were admitted to the Third
ties in the mean values of respective serum lipids examined. Department of Internal Medicine, Wakayama Medical
Although TC levels increased with age, HDL-C levels were College, Japan, for renal biopsy. We evaluated correla-not correlated with age. Hyperlipidemia was observed in 39.8%
tions between serum lipid levels and renal function [cre-of subjects. Significant correlations were observed between
levels of TC, TG, PL, LDL-C, apoB, apoC-II, and apoC-III and atinine clearance (CCr)] and proteinuria (UP). For serum
CCr, UP, and age. Significant correlations were also observed lipids, we took 12-hour fasting blood samples and mea-
between levels of MDA, apoB/apoA-I, apoE/apoC-III, and CCr sured the total cholesterol (TC), triglycerides (TG), high-
and age, as well as between apoE levels and UP and age. The
density lipoprotein cholesterol (HDL-C), phospholipidslevels of apoA-I and apoA-I/apoA-II ratio were significantly
(PL), lipoprotein(a) [Lp(a)], apoA-I, apoA-II, apoB,correlated with UP alone, whereas the apoC-II/apoC-III ratio
was significantly correlated with CCr alone. There were no sig- apoC-II, apoC-III, apoE, and malondialdehyde (MDA).
nificant correlations between levels of HDL-C, apoA-II, and We calculated low-density lipoprotein cholesterol (LDL-
Lp(a) and CCr, UP, and age. C) by this formula: LDL-C 5 TCHDL 2 CTG/5.Conclusions. Age, proteinuria, and renal function were re-
lated with changes in serum lipid levels in IgA nephritis. There
were correlations between proteinuria and levels of apoA, as
RESULTSwell as between renal function and apoC levels.
There were no abnormalities in overall mean values
or standard deviations of serum lipid levels, CCr, UP,
In chronic nephritis and chronic renal failure, athero- levels of apolipoprotein, and apolipoprotein ratios. The
sclerosis is an important factor affecting long-term prog- grouping of hyperlipidemia by phenotype was done. Nor-
nosis. How atherosclerosis acts to affect chronic renal molipidemia was observed in 115 cases (60.2%, M:F ratio
disease is not well defined, but it is evident that lipid was 49:66) of 191 cases and hyperlipidemia in 76 cases
metabolic disorders contribute to the progression of ath- (39.8%; Table 1).
erosclerosis and may influence any glomerular disease We calculated the mean values of TC and HDL-C
levels for each age and sex. Although TC levels increased
with age, HDL-C levels did not correlate with age inKey words: glomerulonephritis, lipid metabolism, chronic renal failure,
metabolic dysfunction, proteinuria. men or women.
In a revolving analysis, significant correlations were 1999 by the International Society of Nephrology
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Table 2. Correlations between creatinine clearance (CCr),Table 1. Grouping of hyperlipidemia (phenotype)
proteinuria (UP) and age and serum lipids levels,
Number affected apolipoproteins and apolipoprotein ratioType of Percent of
hyperlipidemia Male Female total patients CCr UP Age
Normolipidemia 49 66 60.2% Total cholesterol 20.312a 0.394a 0.449a
IIa 10 17 14.1% Triglycerides 20.292a 0.366a 0.328a
IIb 23 8 16.2% HDL cholesterol 0.099 0.085 0.142
III 1 0 0.5% LDL cholesterol 20.346a 0.358a 0.456a
IV 12 5 8.5% Malondialdehyde 20.360d 0.131 0.532b
Phospholipid 20.324a 0.583a 0.376b
Lipoprotein(a) 0.186 0.134 0.080
ApoA-I 0.064 0.243d 20.061
ApoA-II 0.073 0.019 0.097
ApoB 20.385a 0.230d 0.505a
ApoC-II 20.257d 0.309c 0.489aobserved between age and CCr, between age and UP,
ApoC-III 20.413a 0.410a 0.412aand between CCr and UP. We also analyzed correlations ApoE 20.154 0.308c 0.258d
between CCr, UP, and age and serum lipid, apolipopro- ApoA-I/ApoA-II 20.108 0.290c 20.110
ApoB/ApoA-I 20.357b 0.040 0.500atein, and apolipoprotein ratio by revolving analysis (Ta-
ApoC-II/ApoC-III 0.201d 0.100 0.139ble 2). Significant correlations were observed between
ApoE/ApoC-III 0.333d 0.182 20.296c
levels of TC, TG, LDL-C, and PL and CCr, UP, and age
Values are correlation coefficient.
and between MDA and CCr and age. No correlation was a P , 0.0001, b P , 0.001, c P , 0.01, d P , 0.05
observed between levels of HDL-C and other items. As
well, no correlation was observed between levels of
Lp(a) and CCr, UP, and age. Significant correlations were
age. Compared with the Basic Investigation of Circula-observed between apoB, apoC-II, and apoC-III and CCr,
tion Disease of the Ministry of Health and Welfare ofUP, and age, as well as between apoE levels and UP
Japan study, the results here differed in that TC levelsand age. Levels of apoA-I were significantly correlated
were higher in women after their 40s and in men afterwith UP alone. ApoB/apoA and apoE/apoC-III ratios
their 50s. HDL-C levels were not correlated with age inwere significantly correlated with CCr and age, and the
either sex. These results were in agreement with theapoA-I/apoA-II ratio was significantly correlated with
Ministry of Health and Welfare survey in that levels ofUP alone. In addition, the ratio of apoC-II/apoC-III cor-
TC and TG were strongly correlated with age and thatrelated with CCr alone. A positive correlation was ob-
HDL-C levels were not correlated with age. Renal func-served between apoA-I and UP, but no correlation was
tion and urinary protein naturally affected the correla-observed between apoA-II and UP. Therefore, it ap-
tion between TC levels and age because significant corre-pears that apoA-I and apoA-II, which are apolipoprot-
lations were observed between age and renal functioneins of HDL-C, are not influenced by proteinuria.
and urinary protein in these patients. Age and urinaryWe also analyzed correlations between renal function
protein also affected the correlation between TC levels(CCr) and serum lipid and apolipoprotein by t-tests. In
and CCr. A proper analysis required stratification by agethe group where CCr was less than 100 liter/day, levels
or UP for the evaluation of the relationship between CCrof TC, TG, apoB, apoC-II, apoC-III, PL, and MDA were
and lipid metabolism, but that was impossible becausesignificantly higher than the group in which CCr was more
of the number of subjects. In the correlations betweenthan 100 liter/day. Otherwise, there was no difference
each lipid and age, CCr, and UP, the lipid correlated within the levels of HDL-C, apoA-I, apoA-II, apoE, and
only one item of the three. The apoC-II/apoC-III ratiolipoprotein(a).
was strongly correlated positively with only CCr. ApoC-II
is a necessary factor for activation of lipoprotein lipase,
DISCUSSION and it is related to the metabolism of chylomicrons and
very low density lipoprotein (VLDL). Although theHyperlipidemia was observed in 39.8% of the subjects.
Types IIb and IV were the most frequently found in men function of apoC-III has not been established, it has
been reported that it blocks the activation of lipoproteinand type IIa in women. The ratio of type IIb in men was
higher than that reported in the Basic Investigation of lipase by apoC-II and that it increases the activation of
LCAT. In particular, it has been reported that apoC-IIICirculation Disease by the Ministry of Health and Wel-
fare of Japan, 1990, a study of 8000 Japanese people. suppresses triglyceride-rich lipoprotein uptake by the
liver [3]. This suggests that the decrease of apoC-II/Compared with that survey, type IIa was slightly more
frequent in women than in men of our study. Type IV apoC-III ratio will delay metabolism of triglyceride-rich
lipoprotein, resulting in the increase of triglyceride-richwas overwhelmingly more frequent in men, and type IIb
was similar in men and women. TC levels increased with lipoprotein levels in blood. From this, we can anticipate
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